ESH-EBMT Handbook on Haematopoietic Stem Cell Transplantation () 2. ESH Handbook on Immune Thrombocytopenia () 3. ESH Handbook on. Home > ESH-EBMT Handbook on Haematopoietic Stem Cell Transplantation ( ). ESH-EBMT Handbook on Haematopoietic Stem Cell Transplantation. eLearning Center Multiple Myeloma Hub Handbooks EU Projects. Sponsors. ESH Gold Institutional Partner. Celgene ESH Gold Institutional Partner.
|Published (Last):||28 April 2007|
|PDF File Size:||12.80 Mb|
|ePub File Size:||11.43 Mb|
|Price:||Free* [*Free Regsitration Required]|
Stem cell transplant organisations.
Biological properties of haematopoietic stem cells. Beneficial effects of natural killer cell alloreactivity in haploididentical HSCT.
Non-HLA immunogenetics and role in transplant outcome. JACIE accreditation of transplant centres. Sources and procurement of stem cells. Early complications after HSCT.
Graft versus host disease. Long term survivorship, general health status, quality of life and late complications after HSCT. The value of molecular monitoring in haematological malignancy; minimal residual disease MRDrelapse and chimerism.
Immunotherapy post-transplant for infections. Adoptive cellular handbokk to harness post-transplant alloreactivity. Immune reconstitution after allogeneic HSCT.
Psychosocial aspects of HSCT. Indications and current practice for allogeneic and autologous HSCT for haematological diseases, solid tumours and ebmt-esn disorders. Statistical evaluation of HSCT data. Methodology of conducting academic clinical trialsin Europe. HSCT for acute myeloid leukaemia in adults.
Handbooks | ESH – European School of Haematology
HSCT for acute lymphoblastic leukaemia in adults. HSCT for myelodysplasia in adults. HSCT for chronic myeloid leukaemia in adults.
HSCT for myeloproliferate disorders in adults. HSCT for chronic lymphocytic leukaemia in adults.
HSCT for multiple myeloma in adults. HSCT for primary amyloidosis in adults. HSCT for solid tumours in adults. HSCT for autoimmune diseases in adults. HSCT for aplastic anaemia in adults.
HSCT for tissue regeneration in adults. HSCT dbmt-esh acute myeloid leukaemia in children. HSCT for acute lymphoblastic leukaemia in children. HSCT for myelodysplastic syndromes in children.
Recommendations of Project 14: SCT
HSCT for chronic myeloproliferate disorders in children. HSCT for lymphomas in children. HSCT for inborn errors of metabolism. HSCT for hereditary bone marrow failure syndromes.
HSCT in the haemoglobinopathies. Multiple Myeloma Hub Let’s keep in touch! Miami JohnGoldmanConference … https: Now freely avai… https: